{"id":"W2239698670","doi":"10.1016/s1470-2045(15)00518-5","title":"Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":283,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Sanofi; Amgen","keywords":"Enzalutamide; Bicalutamide; Prostate cancer; Medicine; Oncology; Internal medicine; Androgen receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001332027,0.001905232,0.003477713,0.0006213564,0.0004034202,0.001050171,0.001067034,0.001710608,0.005916852],"category_scores_gemma":[0.00201685,0.001032941,0.001628171,0.0005559211,0.001656918,0.001553175,0.0004530268,0.002906377,0.0009587913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007719028,"about_ca_system_score_gemma":0.0009095767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001008508,"about_ca_topic_score_gemma":0.001921472,"domain_scores_codex":[0.9992478,0.0004505158,0.00004033038,0.0001105606,0.00004931176,0.0001013382],"domain_scores_gemma":[0.9990578,0.0002779994,0.0001954898,0.00009132212,0.00005060742,0.0003268039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9867305,0.003656959,0.0002136368,0.0002077304,0.0003599389,0.00001422504,0.0000298196,0.0002191902,0.001877458,0.00003639202,0.0001817549,0.006472397],"study_design_scores_gemma":[0.9085338,0.0891855,0.0009856952,0.00001179269,0.000263757,0.000019331,0.0000163087,0.0002568471,0.0003714229,0.00007373756,0.0002662276,0.00001562574],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941498,0.002114109,0.0004142474,0.0003098115,0.0002582551,0.001121089,0.0004879451,0.00009276095,0.001052063],"genre_scores_gemma":[0.9927905,0.001590258,0.0008323331,0.0005105991,0.0003191584,0.001306367,0.0005447905,0.00003482729,0.002071171],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005916852,"threshold_uncertainty_score":0.01979387,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09227178365285235,"score_gpt":0.4254760336601119,"score_spread":0.3332042500072595,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}